© 2021 Catalani, Arillotta, Corkery, Guirguis, Vento and Schifano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).https://creativecommons.org/licenses/by/4.0/COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of the current research were to use a web crawler, NPSfinder®, to identify and categorize emerging NPS discussed on a range of drug enthusiasts/psychonauts' websites/fora at the time of the pandemic; social media for these identified NPS were screened as well. The NPSfinder® ...
Background: A wide range of novel psychoactive substances (NPSs) are regularly searched and discusse...
Funding: The Associate Laboratory Institute for Health and Bioeconomy–i4HB (project LA/P/0140/2020...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article dist...
© 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article dist...
Simple Summary We presented a comprehensive, systematic literature review of all published New Psych...
In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market...
Submitted 24 November 2018, Revised 18 June 2019, Accepted 26 June 2019, Published online 22 July 20...
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
In the late 2019, an epidemic of cases with severe acute respiratory syndrome coronavirus 2 (SARS-Co...
This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions f...
As new psychoactive substances (NPS) flood the market and “designer drug” sales are on the rise, we ...
© 2020 Bentham Science. This is the accepted manuscript version of an article which has been publish...
Novel Psychoactive Substances (NPSs), also known as legal highs or smart drugs, are legal alternativ...
Background: A wide range of novel psychoactive substances (NPSs) are regularly searched and discusse...
Funding: The Associate Laboratory Institute for Health and Bioeconomy–i4HB (project LA/P/0140/2020...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article dist...
© 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article dist...
Simple Summary We presented a comprehensive, systematic literature review of all published New Psych...
In parallel with a decrease/stabilization in the use of internationally controlled drugs, the market...
Submitted 24 November 2018, Revised 18 June 2019, Accepted 26 June 2019, Published online 22 July 20...
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
In the last decade, the trend of drug consumption has completely changed, and several new psychoacti...
In the late 2019, an epidemic of cases with severe acute respiratory syndrome coronavirus 2 (SARS-Co...
This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions f...
As new psychoactive substances (NPS) flood the market and “designer drug” sales are on the rise, we ...
© 2020 Bentham Science. This is the accepted manuscript version of an article which has been publish...
Novel Psychoactive Substances (NPSs), also known as legal highs or smart drugs, are legal alternativ...
Background: A wide range of novel psychoactive substances (NPSs) are regularly searched and discusse...
Funding: The Associate Laboratory Institute for Health and Bioeconomy–i4HB (project LA/P/0140/2020...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...